Young Adults with Multiple Myeloma
Objective:
To identify the salient issues of young adults (YAs) diagnosed with multiple myeloma (MM), a hematologic disease of older adults, that is rare in patients 19-40 years of age.
Data Sources:
Peer-reviewed journal articles, case reports, single-institution series, and national guidelines.
Conclusion:
Compared to older adults with MM, YAs live longer and are at higher risk for survivorship-related issues, which include treatment adherence, infertility, reproductive concerns, risk of second primary cancers, treatment-related cardiotoxicity, and higher risk of non-cancer-related mortality.
Implications For Nursing Practice:
In addition to understanding disease biology, the oncology nurse should have an understanding of the unique developmental, psychosocial, and medical and psychosocial needs of the young adult with MM. The oncology nurse will then be able to provide targeted education about the disease, its treatment trajectory, and supportive care issues, as well as advocate for therapies, and based on response, toxicities, while taking into consideration patient-centered needs.
More Related Videos
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Treatment Resistant Cancers
Adult Stem Cells
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Differentiation of Common Myeloid Progenitor Cells
